regulatory ai governance

This tag covers discussions on regulatory AI governance, focusing on how artificial intelligence is being applied to streamline regulatory processes in industries like pharmaceuticals. Topics include AI-assisted site selection for clinical trials, automated drafting of regulatory submissions, and the governance frameworks needed to ensure compliance and safety. The content explores the balance between accelerating drug development through AI and maintaining rigorous oversight, reflecting the growing intersection of AI technology with regulatory affairs in enterprise and healthcare settings.